(Q48204788)

9 February 2018

title

Decreased neointimal extracellular matrix formation in RAGE-knockout mice after microvascular denudation. (English)

1 reference

9 February 2018

0 references

6

Claus Claussen

1 reference

9 February 2018

author name string

Gerd Grözinger

1

1 reference

9 February 2018

Jörg Schmehl

2

1 reference

9 February 2018

Rüdiger Bantleon

3

1 reference

9 February 2018

Rainer Kehlbach

4

1 reference

9 February 2018

Tarun Mehra

5

1 reference

9 February 2018

Benjamin Wiesinger

7

1 reference

9 February 2018

publication date

10 December 2011

1 reference

9 February 2018

CardioVascular and Interventional Radiology

published in

1 reference

9 February 2018

volume

35

1 reference

9 February 2018

issue

6

1 reference

9 February 2018

page(s)

1439-1447

1 reference

9 February 2018

https://scigraph.springernature.com/pub.10.1007/s00270-011-0319-3

exact match

0 references

cites work

Oxidative stress, AGE, and atherosclerosis

1 reference

https://api.crossref.org/works/10.1007%2FS00270-011-0319-3

Drug-eluting and bare nitinol stents for the treatment of atherosclerotic lesions in the superficial femoral artery: long-term results from the SIROCCO trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00270-011-0319-3

Central role of RAGE-dependent neointimal expansion in arterial restenosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00270-011-0319-3

Kinetics, role and therapeutic implications of endogenous soluble form of receptor for advanced glycation end products (sRAGE) in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00270-011-0319-3

Receptor for advanced glycation end products (RAGE) mediates neuronal differentiation and neurite outgrowth.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00270-011-0319-3

Characterization of a novel EGFP reporter mouse to monitor Cre recombination as demonstrated by a Tie2 Cre mouse line

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00270-011-0319-3

Microvascular denudation of the femoral artery of the mouse as a model for restenosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00270-011-0319-3

The myeloperoxidase system of human phagocytes generates Nepsilon-(carboxymethyl)lysine on proteins: a mechanism for producing advanced glycation end products at sites of inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00270-011-0319-3

Sp1-binding elements in the promoter of RAGE are essential for amphoterin-mediated gene expression in cultured neuroblastoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00270-011-0319-3

Characterization and functional analysis of the promoter of RAGE, the receptor for advanced glycation end products

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00270-011-0319-3

Release of chromatin protein HMGB1 by necrotic cells triggers inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00270-011-0319-3

Atherosclerosis and diabetes: the RAGE connection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00270-011-0319-3

Activation of the receptor for advanced glycation end products triggers a p21(ras)-dependent mitogen-activated protein kinase pathway regulated by oxidant stress.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00270-011-0319-3

Diabetes-associated sustained activation of the transcription factor nuclear factor-kappaB

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00270-011-0319-3

Multiple levels of regulation determine the role of the receptor for AGE (RAGE) as common soil in inflammation, immune responses and diabetes mellitus and its complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00270-011-0319-3

Advanced glycation end products cause epithelial-myofibroblast transdifferentiation via the receptor for advanced glycation end products (RAGE)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00270-011-0319-3

Extracellular matrix changes in stented human coronary arteries

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00270-011-0319-3

Metalloproteinase inhibitors: biological actions and therapeutic opportunities.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00270-011-0319-3

S100A12 mediates aortic wall remodeling and aortic aneurysm

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00270-011-0319-3

Antiproliferative effects of the antiallergic agent azelastine on human aortic smooth-muscle cells: an in vitro study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00270-011-0319-3

Endothelin A receptor antagonist LU 135252 inhibits hypercholesterolemia-induced, but not deendothelialization-induced, atherosclerosis in rabbit arteries

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00270-011-0319-3

Delayed intervention with AGE inhibitors attenuates the progression of diabetes-accelerated atherosclerosis in diabetic apolipoprotein E knockout mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00270-011-0319-3

Preventative effects of rosiglitazone on restenosis after coronary stent implantation in patients with type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00270-011-0319-3

RAGE and its ligands in retinal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00270-011-0319-3

Role of toll-like receptors 2 and 4, and the receptor for advanced glycation end products in high-mobility group box 1-induced inflammation in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00270-011-0319-3

Involvement of membrane type 1-matrix metalloproteinase (MT1-MMP) in RAGE activation signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00270-011-0319-3

Receptor for Advanced Glycation End Products (RAGE)—Soluble Form (sRAGE) and Gene Polymorphisms in Patients with Breast Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00270-011-0319-3

10.1007/S00270-011-0319-3

21 January 2018

Identifiers

DOI

1 reference

9 February 2018

release_lo3lyfqjknem5cqf34ap7u73ci

Fatcat ID

0 references

1 reference

9 February 2018